CoraVie Medical, a startup developing an implantable continuous blood pressure monitor, recently won the medical devices track of MedCity News’ INVEST Pitch Perfect contest. The pre-revenue company’s remote management solution monitors for the early detection of dangerous blood pressure levels to prevent crises that could lead to heart attack, stroke, kidney failure or death.

The post INVEST Pitch Perfect Spotlight: CoraVie Medical’s Mission to Transform the Way We Monitor Blood Pressure appeared first on MedCity News.

Mineralys Therapeutics upsized its IPO, raising capital to finance clinical trial plans for a molecule that could become an alternative to currently available hypertension medicines. The Mineralys molecule takes a similar approach to a drug candidate that AstraZeneca is acquiring in a $1.3 billion deal.

The post Mineralys IPO Lands $192M for Blood Pressure Trials and Chance to Challenge AstraZeneca appeared first on MedCity News.

CardieX, a cardiovascular technology company based in both Australia and Illinois, recently acquired Blumio, a San Mateo, California-based startup focused on cardiovascular sensors. The deal will advance both companies’ vision to accurately and easily measure blood pressure without relying on the use of a cuff.

The post CardieX Acquires Blumio, Incorporates Its Wearable Blood Pressure Sensor appeared first on MedCity News.

The Series D funding round was led by growth equity firm Stripes. Hello Heart’s latest haul brings the total amount the company has raised since its founding in 2013 to $138 million.

The post RPM company Hello Heart scores $70M from investors appeared first on MedCity News.

A large study published in JAMA Network Open found that people with stage II hypertension were able to reduce their systolic blood pressure and maintain it over three years using Hello Heart’s app. 

The post Hello Heart study shows potential for digital tools to help manage blood pressure  appeared first on MedCity News.

According to a report by the Wall Street Journal, Apple is planning to add more health features to its watch, including a feature to track blood pressure and a wrist-based thermometer.

The post Report: Apple Watch to add blood pressure, thermometer features appeared first on MedCity News.

Fitbit is launching a trial to see if its its newest smartwatch could use pulse arrival time to measure blood pressure. Other wearable companies have tried to add wrist-based blood pressure features to their devices, but so far, they have limited accuracy. 

The post Fitbit tests if smartwatch could measure blood pressure appeared first on MedCity News.

Providing care for chronic disease patients during a one-in-a-century pandemic is full of challenges, but health systems like Jefferson Health are finding ways — with help from technology — to make sure their patients are getting the care they need.

The post How Jefferson Health is caring for chronic disease patients amid a pandemic appeared first on MedCity News.

Livongo has revealed a new voice-enabled blood pressure monitoring system, which is powered by Amazon Lex and Amazon Polly.

The post Amazon powers Livongo’s new voice-enabled hypertension tool appeared first on MedCity News.

The pre-order price of the device is $499 and it will be available in retail stores starting in January.

The post Omron Healthcare launches wearable blood pressure monitor after FDA nod appeared first on MedCity News.

Every digital health startup wants clinical validation, but studies have unexpected results. That’s what appears to have greeted Medisafe when it ventured to gather real-world evidence about its mobile health tool.

The post Contemplating a research study to validate an app? Read this first. appeared first on MedCity News.

Qardio’s three products — QardioArm, QardioBase and QardioCore — have been integrated onto Tactio Health Group’s digital platform.

The post Qardio integrates digital health products onto Tactio’s platform appeared first on MedCity News.

The agreement bars Aura Labs and founder Ryan Archdeacon from claiming that the Instant Blood Pressure app is as accurate as a traditional blood pressure cuff.

The post FTC’s settlement with blood pressure app developer echoes frustration with misleading claims appeared first on MedCity News.